LUMICKS
PrivateLast Round
Debt
Oct 10, 2024
Total Funding Raised
$120.76M
Company Overview
LUMICKS is a life sciences tools company that develops innovative instruments for dynamic single-molecule and cell avidity analysis to uncover unique molecular and cellular interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LUMICKS Comparables
Compare LUMICKS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Impetux Optics | 77% | |
| Nicoya Lifesciences Inc. | 74% | |
| Aresis d.o.o. | 74% | |
LUMICKS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 10, 2024 | ||||
| Series D | Apr 16, 2021 | ||||
| Grant | Oct 1, 2020 | ||||
| Grant | May 12, 2015 | ||||
| Debt | Jan 15, 2015 |
LUMICKS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series D |
| Farallon Capital Management | Series D |
| SoftBank Group | Series D |
| Lauxera Capital Partners | Series D |
| Gilde Healthcare | Series D, Series A |
| Irving Investors | Series D |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2024
$22M round led by European Investment Bank Group.
- Apr 16, 2021
$93M round led by Farallon Capital Management and Lauxera Capital Partners.
LUMICKS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LUMICKS's valuation, stock price, and market status.